Lidocaine infusion increased beta-endorphin equally in diabetic neuropathy patients and controls, but pain relief in patients did not correlate with endorphin changes.
Pain relief independent of endorphinsLidocaine neuropathy relief through nerve-blocking, not opioid mechanisms
What the researchers found
Lidocaine increased plasma beta-endorphin equally in patients and controls, but pain relief in diabetic neuropathy was not correlated with beta-endorphin changes.
Why it matters
This suggests lidocaine relieves diabetic nerve pain through a mechanism other than the opioid system. The beta-endorphin rise appears to be a general response to lidocaine, not specific to pain relief.
How the study worked
Blood opioid peptides were measured by radioimmunoassay before and after lidocaine infusion in 8 diabetic neuropathy patients and 10 controls. Pain was scored before and after treatment.
What this study cannot tell us
Very small study with only 8 patients. Only blood peptide levels were measured, which may not reflect what happens in the nervous system. No placebo control.
How to read the evidence
Preliminary cross-sectional study — small but with direct plasma peptide measurements.
When this study was published
Published in 1989 — clarified lidocaine mechanism in neuropathic pain.
The bigger picture
Lidocaine pain relief in neuropathy appears to work through direct nerve effects, not the opioid system. This is important for understanding and optimizing neuropathic pain treatments.
Questions still open
- Could combining lidocaine with opioid peptide therapy improve outcomes?
- Why does lidocaine increase endorphins if the mechanism is non-opioid?
Common questions
How does lidocaine relieve nerve pain?
Why did endorphins increase if they did not cause the pain relief?
Read the original research
Lidocaine treatment of painful diabetic neuropathy and endogenous opioid peptides in plasma.
The Clinical journal of pain, 5(3), 239-44
Citation
Kastrup, J; Bach, F W; Petersen, P; Dejgård, A; Ekman, R; Jensen, S; Angelo, H. (1989). Lidocaine treatment of painful diabetic neuropathy and endogenous opioid peptides in plasma.. The Clinical journal of pain, 5(3), 239-44.